Form 4: AnaptysBio Director John A. Orwin Reports Stock Transactions
SEC Form 4 Filing
Director John A. Orwin reports the vesting and disposal of restricted stock units in AnaptysBio, Inc.
Summary
- On September 15, 2024, Director John A. Orwin vested 1,300 restricted stock units (RSUs) of AnaptysBio, Inc. and disposed of 3,335 shares of common stock.
- The vesting of the RSUs occurred at no cost.
- Following the reported transactions, Orwin directly owns 2,600 derivative securities and 3,335 shares of common stock.
- The RSUs vest in three equal installments on September 15, 2024, September 15, 2025, and September 15, 2026, contingent upon continued service to the company.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The remaining RSUs will vest in two tranches on September 15, 2025 and September 15, 2026, contingent upon continued service to the company.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It is common for directors and officers to receive stock-based compensation, and the vesting and subsequent sale of shares are typical events.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 09/15/2024 | Date of earliest transaction: Vesting of 1,300 RSUs and disposal of 3,335 shares. |
| 09/15/2024 | First vesting date for 1/3 of the total RSUs. |
| 09/15/2025 | Second vesting date for 1/3 of the total RSUs. |
| 09/15/2026 | Third vesting date for 1/3 of the total RSUs. |
| 09/17/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.